💉CDC Announces Meeting on Immunization Practices and Public Comment
In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces the following meeting of the Advisory Committee on Immunization Practices (ACIP). Time will be available for public comment.
Learn More📊CDC Seeks Comments on Proposed Data Management Plan Template
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a proposed information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Data Management Plan (DMP) Template. The proposed data collection will allow CDC to have a consistent and unified approach for CDC Programs to develop their own Data Management Plans (DMPs).
Learn More🎍CDC Rescinds Lucky Bamboo Import Embargo
Based on a review of existing import requirements, CDC has determined that the import restrictions for Dracaena (Lucky Bamboo) shipped in standing water are no longer necessary to protect the public's health and should therefore be rescinded. Accordingly, effective immediately, CDC is rescinding its embargo on importation of Dracaena Shipments in Standing Water (July 10, 2001).
Learn More🐐CDC Rescinds Ban on Haitian Goatskin Handicrafts Importation
Based on a review of existing import requirements, CDC has determined that the import requirements for goatskin handicrafts from Haiti are no longer necessary to protect the public's health and should therefore be rescinded. Accordingly, effective immediately, CDC is rescinding the advisory memorandum order banning the importation of Haitian goatskin handicrafts (August 14, 1981).
Learn More🦠CDC Sets Roadmap for Accelerated HCV Diagnosis and Treatment
The Centers for Disease Control and Prevention (CDC) announces a two-day convening hosted and facilitated by the Association of Public Health Laboratories (APHL) to discuss hepatitis C diagnostics. Leaders from public health, laboratory, medical, academic, and industry sectors will have the opportunity to provide individual input, without building a consensus, on accelerating the diagnosis of current hepatitis C virus (HCV) infection. Members of the public with interest and expertise in diagnosing HCV infection are also invited to provide individual input. Specifically, the convening will focus on how to leverage the following hepatitis C diagnostic methods: same-day diagnosis and treatment, and viral-first testing.
Learn More🩺CDC Notice on National Outbreak Reporting System Compliance
The CDC has submitted a request for information collection regarding the National Outbreak Reporting System (NORS) to the OMB for review. This web-based platform facilitates the reporting of waterborne and foodborne disease outbreaks, enabling local and state health departments to provide critical data for public health analysis and intervention. Comments on the proposed collection are being accepted for 30 days.
Learn More💊FDA Workshop on CMC Development
The Food and Drug Administration (FDA, the Agency, or we) is announcing a virtual-only public workshop entitled "Lessons Learned From the Chemistry, Manufacturing, and Controls (CMC) Development and Readiness Pilot (CDRP) Program." This workshop fulfills a commitment in the seventh authorization of the Prescription Drug User Fee Act (PDUFA VII) to hold a public meeting to discuss best practices and lessons learned from this pilot program. Convened by the Duke-Robert J. Margolis, MD Center for Health Policy (Duke-Margolis) and supported by a cooperative agreement between FDA and Duke-Margolis, the workshop will feature sponsors and FDA experience under this pilot program and will solicit input on future directions for FDA policy and programs to facilitate expedited CMC development of products under an investigational new drug application (IND), where indicated based upon the anticipated clinical benefits.
Learn More🚢CDC Continues Sanitation Inspection Fees for Cruise Industry
The Centers for Disease Control and Prevention (CDC), within the Department of Health and Human Services (HHS) announces the vessel sanitation inspection fees instituted in fiscal year (FY) 2025 will continue in FY 2026 and remain in place until further notice or a modification is published. These inspections are conducted by HHS/CDC's Vessel Sanitation Program (VSP). VSP helps the cruise line industry fulfill its responsibility for developing and implementing comprehensive sanitation programs to minimize the risk for environmentally associated illnesses and hazards. Every vessel that has a foreign itinerary and carries 13 or more passengers is subject to twice-yearly unannounced operations inspections and, when necessary, reinspection.
Learn More🧪CDC Proposes Data Collection for Laboratory Response Network
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies to take this opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Laboratory Response Network. This collection will allow CDC to continue to track laboratory testing capacity, capability, and distribution to ensure all areas of the nation are protected during a public health emergency response.
Learn More🏥ICD-10 Coordination and Maintenance Committee Meeting Notice
The Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), Classifications and Public Health Data Standards Staff, announces the following meeting of the ICD-10 Coordination and Maintenance (C&M) Committee. This meeting is open to the public, limited only by the number of audio lines available. Online registration is required.
Learn More